Clinical Trials Logo

Clinical Trial Summary

Patients with Dent disease have suppressed levels of FGF 23 which contributes to hypercalciuria, kidney stones, nephrocalcinosis and renal failure. Supplementation with phosphorus may reduce hypercalciuria.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02016235
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase Phase 1/Phase 2
Start date September 2014
Completion date January 2019

See also
  Status Clinical Trial Phase
Completed NCT02022189 - Review of Kidney Biopsies of Dent Disease Patients N/A
Recruiting NCT06065852 - National Registry of Rare Kidney Diseases
Recruiting NCT02780297 - Prospective Research Rare Kidney Stones (ProRKS)
Recruiting NCT02026388 - Rare Kidney Stone Consortium Biobank
Completed NCT04459013 - Evaluation of the Release of Monomers From Composite Bonding Resins in Orthodontics
Not yet recruiting NCT06017193 - Ultrasound for Socket Healing Evaluation
Recruiting NCT00588562 - Rare Kidney Stone Consortium Patient Registry
Completed NCT02124395 - Health-related Quality of Life in Rare Kidney Stone
Completed NCT01783795 - Dent Disease Mutation Genotyping N/A